Nathan W. Sweeney
Nathan W. Sweeney publishes mostly in Hematology, Oncology and Molecular Biology, on topics such as Multiple Myeloma Research and Treatments, Cancer Treatment and Pharmacology and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #4,765,493 of 7,710,434 ranked researchers
- Rank in United States
- #1,251,189 of 1,627,098
- Works
- 58
- Citations
- 96
- Citations per work
- 1.7
What does Nathan W. Sweeney research?
Nathan W. Sweeney's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (11%), Economics, Econometrics and Finance (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2441.7%
- Medicine2441.7%
- Everything else1933.2%
- Life Sciences914.9%
- Social Sciences610.2%
- 1Hematology17% of their works
- 2Oncology16% of their works
- 3Molecular Biology11% of their works
- 4Economics and Econometrics10% of their works
- 5Epidemiology8% of their works
- 6Immunology4% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Cancer Treatment and Pharmacology
- Health Systems, Economic Evaluations, Quality of Life
- CAR-T cell therapy research
- Pharmaceutical Economics and Policy
- Cancer, Hypoxia, and Metabolism
- Genetics, Bioinformatics, and Biomedical Research
- Protein Degradation and Inhibitors
Which keywords describe Nathan W. Sweeney's research?
The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, Quality of Life, Chemotherapy-Induced Peripheral Neuropathy, Cost-effectiveness Analysis, Health Utility Measures, Taxanes and CAR T Cells.
- PROTACs
- Education
- BET Bromodomains
- Drug Development Costs
- CAR T Cells
- Health Utility Measures
- Chemotherapy-Induced Peripheral Neuropathy
- International Myeloma Working Group
- Diagnosis Criteria
- Quality of Life
- Cost-effectiveness Analysis
- Taxanes
- Chimeric Antigen Receptor
- Generic Drugs
- Bioinformatics
- HIF-1
- Warburg Effect
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Diagnosis Criteria211 topic
- International Myeloma Working Group211 topic
- Quality of Life122 topics
- Chemotherapy-Induced Peripheral Neuropathy61 topic
- Cost-effectiveness Analysis61 topic
- Health Utility Measures61 topic
- Taxanes61 topic
- CAR T Cells51 topic
- Chimeric Antigen Receptor51 topic
- Drug Development Costs41 topic
- Generic Drugs41 topic
- BET Bromodomains31 topic
- Bioinformatics31 topic
- Education31 topic
- HIF-131 topic
- PROTACs31 topic
- Warburg Effect31 topic
Where does Nathan W. Sweeney work?
Nathan W. Sweeney's main affiliation in the publication record is EvergreenHealth Foundation, United States.
How many publications and citations does Nathan W. Sweeney have?
OpenAlex counts 58 works and 96 citations for Nathan W. Sweeney, an h-index of 5, ranking #4,765,493 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nathan W. Sweeney. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.